1. Academic Validation
  2. Nutrient availability regulates the secretion and function of immune cell-derived extracellular vesicles through metabolic rewiring

Nutrient availability regulates the secretion and function of immune cell-derived extracellular vesicles through metabolic rewiring

  • Sci Adv. 2024 Feb 16;10(7):eadj1290. doi: 10.1126/sciadv.adj1290.
Yizhuo Wang 1 Peng Lou 1 Yijing Xie 1 Shuyun Liu 1 Lan Li 1 Chengshi Wang 2 Dan Du 3 Younan Chen 1 Yanrong Lu 1 Jingqiu Cheng 1 Jingping Liu 1
Affiliations

Affiliations

  • 1 Department of General Surgery and NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu 610041, China.
  • 2 Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu 610041, China.
  • 3 Advanced Mass Spectrometry Center, Research Core Facility, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu 610041, China.
Abstract

Extracellular vesicle (EV)-based immunotherapeutics have emerged as promising strategy for treating diseases, and thus, a better understanding of the factors that regulate EV secretion and function can provide insights into developing advanced therapies. Here, we report that nutrient availability, even changes in individual nutrient components, may affect EV biogenesis and composition of immune cells [e.g., macrophages (Mφs)]. As a proof of concept, EVs from M1-Mφ under glutamine-depleted conditions (EVGLN-) had higher yields, functional compositions, and immunostimulatory potential than EVs from conventional GLN-present medium (EVGLN+). Mechanistically, the systemic metabolic rewiring (e.g., altered energy and redox metabolism) induced by GLN depletion resulted in up-regulated pathways related to EV biogenesis/cargo sorting (e.g., ESCRT) and immunostimulatory molecule production (e.g., NF-κB and STAT) in Mφs. This study highlights the importance of nutrient status in EV secretion and function, and optimizing metabolic states and/or integrating them with other engineering methods may advance the development of EV therapeutics.

Figures
Products
Inhibitors & Agonists
Other Products